In breast cancer, IGF-1 regulates cell growth through stimulation of the insulin growth factor receptor (IGF-1R), which consequently phosphorylates either insulin receptor substrate-1 (IRS-1) or insulin receptor substrate-2 (IRS-2). Here, IRS2 is linked to breast carcinoma.